These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1975015)

  • 1. "Treating through" hypersensitivity to cotrimoxazole in children with HIV infection.
    Kreuz W; Güngör T; Lotz C; Funk M; Kornhuber B
    Lancet; 1990 Aug; 336(8713):508-9. PubMed ID: 1975015
    [No Abstract]   [Full Text] [Related]  

  • 2. Trimethoprim-sulfamethoxazole (cotrimoxazole) desensitization in an HIV-infected 5-yr-old girl.
    Gómez-Traseira C; Boyano-Martínez T; Escosa-García L; Pedrosa M; Martín-Muñoz F; Quirce S
    Pediatr Allergy Immunol; 2015 May; 26(3):287-289. PubMed ID: 25692246
    [No Abstract]   [Full Text] [Related]  

  • 3. Trimethoprim-sulfamethoxazole oral desensitization in hemophiliacs infected with human immunodeficiency virus with a history of hypersensitivity reactions.
    Kletzel M; Beck S; Elser J; Shock N; Burks W
    Am J Dis Child; 1991 Dec; 145(12):1428-9. PubMed ID: 1688295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylaxis against Pneumocystis carinii pneumonia in children with HIV.
    Raphael SA; Lischner HW; Gregonis S
    JAMA; 1991 Aug; 266(8):1078-9. PubMed ID: 1865535
    [No Abstract]   [Full Text] [Related]  

  • 5. Rapid oral desensitization to trimethoprim-sulfamethoxazole in infants and children.
    Palusci VJ; Kaul A; Lawrence RM; Haines KA; Kwittken PL
    Pediatr Infect Dis J; 1996 May; 15(5):456-60. PubMed ID: 8724071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A severe systemic reaction to trimethoprim-sulfamethoxazole in a patient infected with the human immunodeficiency virus.
    Martin GJ; Paparello SF; Decker CF
    Clin Infect Dis; 1993 Jan; 16(1):175-6. PubMed ID: 8448303
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful desensitization in a child with delayed cotrimoxazole hypersensitivity: A case report.
    D'Amelio CM; Del Pozo JL; Vega O; Madamba R; Gastaminza G
    Pediatr Allergy Immunol; 2016 May; 27(3):320-1. PubMed ID: 26660294
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful desensitization to dapsone for Pneumocystis carinii prophylaxis in an HIV-positive patient.
    Cook DE; Kossey JL
    Ann Pharmacother; 1998 Dec; 32(12):1302-5. PubMed ID: 9876811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Hypersensitivity to Trimethoprim-Sulfamethoxazole With an Ultrarapid Desensitization Protocol in HIV Infection.
    Villarreal-González RV; González-Díaz SN; Canel Paredes A; De Lira-Quezada CE; Rocha-Silva GK; López Méndez A
    J Investig Allergol Clin Immunol; 2021 Feb; 32(1):66-68. PubMed ID: 34014167
    [No Abstract]   [Full Text] [Related]  

  • 10. Predicting cutaneous hypersensitivity reactions to cotrimoxazole in HIV-infected individuals receiving primary Pneumocystis carinii pneumonia prophylaxis.
    Hennessy S; Strom BL; Berlin JA; Brennan PJ
    J Gen Intern Med; 1995 Jul; 10(7):380-6. PubMed ID: 7472686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desensitization to trimethoprim/sulfamethoxazole in HIV-infected patients.
    Absar N; Daneshvar H; Beall G
    J Allergy Clin Immunol; 1994 Jun; 93(6):1001-5. PubMed ID: 8006304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A life-threatening adverse reaction during trimethoprim-sulfamethoxazole desensitization in a previously hypersensitive patient infected with human immunodeficiency virus.
    Caumes E; Guermonprez G; Winter C; Katlama C; Bricaire F
    Clin Infect Dis; 1996 Dec; 23(6):1313-4. PubMed ID: 8953079
    [No Abstract]   [Full Text] [Related]  

  • 13. Tolerance induction to cotrimoxazole.
    Nucera E; Schiavino D; Buonomo A; Del Ninno M; Sun JY; Patriarca G
    Allergy; 2000 Jul; 55(7):681-2. PubMed ID: 10921475
    [No Abstract]   [Full Text] [Related]  

  • 14. Prospective randomized comparison of toxicity of two prophylactic regimens of cotrimoxazole in leukemic children.
    Aricò M; Molinari E; Bacchella L; DeAmici M; Raiteri E; Burgio GR
    Pediatr Hematol Oncol; 1992; 9(1):35-40. PubMed ID: 1558774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cotrimoxazole for prophylaxis or treatment of opportunistic infections of HIV/AIDS in patients with previous history of hypersensitivity to cotrimoxazole.
    Lin D; Li WK; Rieder MJ
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005646. PubMed ID: 17443608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfonamide Hypersensitivity: Fact and Fiction.
    Khan DA; Knowles SR; Shear NH
    J Allergy Clin Immunol Pract; 2019; 7(7):2116-2123. PubMed ID: 31495421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute psychosis related to use of trimethoprim/sulfamethoxazole in the treatment of HIV-infected patients with Pneumocystis jirovecii pneumonia: a multicentre, retrospective study.
    Lee KY; Huang CH; Tang HJ; Yang CJ; Ko WC; Chen YH; Lee YC; Hung CC
    J Antimicrob Chemother; 2012 Nov; 67(11):2749-54. PubMed ID: 22821870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe co-trimoxazole reaction in a man with AIDS.
    Shepherd J; Shepherd C; Tonozzi C; Boysen E
    J Am Board Fam Pract; 1995; 8(2):130-3. PubMed ID: 7778481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desensitization to co-trimoxazole (trimethoprim-sulphamethoxazole) in HIV-infected patients: is patch testing a useful predictor of reaction?
    Gompels MM; Simpson N; Snow M; Spickett G; Ong E
    J Infect; 1999 Mar; 38(2):111-5. PubMed ID: 10342651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerance of intermittent versus daily cotrimoxazole for PCP prophylaxis in HIV-positive patients.
    MacGregor RR; Morgan AS; Graziani AL; Pietroski NA; Frank I; Braffman MN; Stern JJ; Buckley RM
    Am J Med; 1992 Feb; 92(2):227-9. PubMed ID: 1543214
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.